Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer - Wikidata - awgldk - TriplyDB

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

http://www.wikidata.org/entity/Q35022212

about

Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy--a randomized trial.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality.Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.Clinical usefulness of bone markers in prostate cancer with bone metastasis.Dairy intake in relation to prostate cancer survival.

P2860

Q35569309-F57C952C-C271-458C-B6AE-D8CE8B67CC44 Q35815607-E9CA54ED-DBC9-483F-B125-8643D564296C Q35959956-03E53227-D6DD-4D91-AEF9-7CA1323097D9 Q35985440-7EE1B7EB-FC74-4AE1-9FDD-5C3A210E359E Q36583142-177B3DCD-3210-432D-B2C9-FDFE30C9C3B6 Q37003299-7F703B5B-5984-4079-97D3-50F42A3DD209 Q38026966-CE32EA57-F65A-45FC-824D-187243185846 Q38967037-9CEBD98E-117A-40BB-831D-6603C7197CFF

P2860

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

http://www.wikidata.org/entity/Q35022212

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@ast

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@en

type

label

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@ast

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@en

prefLabel

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@ast

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@en

P1433

Q35022212-BBCF9A7A-B33F-4C04-93CC-BA42EE39128C

P1476

Q35022212-16EB7F84-80A3-4BE4-87BF-91FA25847DD8

P2093

Q35022212-2502A637-8358-4DC8-9EC1-95D236F5918E

Q35022212-8DD7B171-4349-4574-937C-420657685355

Q35022212-C51AAEBA-0D5C-4640-BA53-52B80D77CD24

P2860

Q35022212-0AE0ABC0-6409-4E67-88D6-7ECB8B6F9E4E

Q35022212-1C67BC96-49C0-4269-A2E3-23C03C0797F6

Q35022212-1ECA351A-687B-48F8-BC1F-48A235850CD4

Q35022212-22BCD64A-A307-43AF-A110-4EA4553C4BC8

Q35022212-28BA1998-E949-4663-A93A-D7BB37E65C3D

Q35022212-2E2D2ABA-45D0-4124-BAC9-9EDAC9CC8D44

Q35022212-2E8758F5-5EBF-431B-ADD8-1C2C91FC2216

Q35022212-3210606D-413D-4202-B4C2-F1A0EF1808EC

Q35022212-380B35E6-D63B-4926-B2C3-9E64D4D3F5BE

Q35022212-3836151D-54B3-437D-ADB6-3DDBD9DAE04F

P304

Q35022212-26AB6CCC-7EBA-41C0-A2DA-C6DBEC6F8751

P31

Q35022212-ABEECB88-BF45-4AB4-84A1-C3F23A1DF51B

Q35022212-faa8accd-7806-424c-a4cf-d5760e9e6f10

P356

Q35022212-4C062135-2D6C-44C9-A418-2599978C1ECE

P433

Q35022212-8DE164D4-9B4E-4BB9-9751-BDE3A99AEF2D

P478

Q35022212-8AEA8741-1888-425D-BB13-46C5EDCCBC07

P577

Q35022212-E5909F5F-98BA-4CAD-BDC2-983516D53ED6

P5875

Q35022212-91EFF936-D4CE-4C2D-B507-BD753D5A752E

P698

Q35022212-5DCDB757-F8CA-4B09-A9DC-3EB8EAEDA567

P932

Q35022212-D2A647BF-78DD-4182-85DE-7B5B87D86FED

P356

J.UROLONC.2010.08.007

P1433

Urologic Oncology

P1476

Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer

@en

P2093

Fred Saad

http://www.w3.org/2001/XMLSchema#string

James A Eastham

http://www.w3.org/2001/XMLSchema#string

Matthew R Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoclasts are active in bone forming metastases of prostate cancer patients

Bisphosphonates for breast cancer

Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach.

The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone.

Biochemical markers and skeletal metastases.

Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.

Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer.

Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases.

Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.

P304

369-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2010.08.007

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49688619

http://www.w3.org/2001/XMLSchema#string

P698

21163673

http://www.w3.org/2001/XMLSchema#string

P932

3107360

http://www.w3.org/2001/XMLSchema#string